Protecting specific area of the brain during radiation therapy substantially reduces memory loss

University of Maryland School of Medicine researcher: Better-than-expected results warrant larger, randomized study

2013-09-24

(Press-News.org) ATLANTA – Sept. 23, 2013. Protecting the stem cells that reside in and around the hippocampus – a C-shaped area in the temporal lobe on both sides of the brain associated with the ability to form and store memories – substantially reduces the rate of cancer patients' memory loss during whole-brain radiotherapy without a significant risk of recurrence in that area of the brain, a new study shows. Results of the Phase II clinical trial of patients with brain metastases are being presented today at the American Society for Radiation Oncology (ASTRO) annual meeting.

"Memory loss, especially short-term recall, is an important consideration for patients receiving whole-brain radiotherapy," says the study's co-principal investigator, Minesh P. Mehta, M.B., Ch.B., professor of radiation oncology at the University of Maryland School of Medicine. "We found that reducing the radiation dose to the stem-cell niches surrounding the hippocampus during treatment was clearly associated with memory preservation without an inordinate risk of relapse in that portion of the brain. The findings far exceeded our expectations."

Based on previous research, the predicted rate of cognitive decline at four months for patients receiving whole-brain radiation for brain metastases was 30 percent. Researchers designed the clinical trial so that a positive result would be a rate reduced by half, to 15 percent. The observed rate in the trial was actually 7 percent – significantly better than the baseline rate of 30 percent. With a third fewer patients to evaluate, the rate of decline observed at six months was 2 percent, although comparable data from the historic control study were not available.

"These Phase II results, while not absolutely conclusive, offer very important insights which we hope to validate in a larger, randomized Phase III clinical trial," says Dr. Mehta, a radiation oncologist at the University of Maryland Marlene and Stewart Greenebaum Cancer Center who chairs the Radiation Therapy Oncology Group (RTOG) brain tumor committee. The RTOG, which managed the Phase II trial, also plans to manage the Phase III Study.

Co-principal investigator Vinai Gondi, M.D., will present the findings at the plenary session at the ASTRO annual meeting in Atlanta. He practices at Central DuPage Hospital Cancer Center in Warrenville, Ill.

E. Albert Reece, M.D., Ph.D., M.B.A., vice president for medical affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and Dean of the University of Maryland School of Medicine, says, "Preserving neurocognitive function is extremely important in treating patients with brain metastases, and the results of this latest study on hippocampal-avoidance radiotherapy led by Dr. Mehta are very encouraging. This technique, if validated in a randomized clinical trial, will give physicians a significant new tool to help maintain patients' quality of life while aggressively treating their cancer."

Patients in the study, the majority of them with lung cancer that had spread to the brain, were treated with intensity-modulated radiation therapy (IMRT), which enabled doctors to shape the radiation beams to avoid the hippocampus. Researchers used a standardized cognitive function assessment – the Hopkins Verbal Learning Test (HVLT) – to measure patients' baseline memory, such as their ability to recall information immediately or after a delay, with follow-up at two, four and six months.

A total of 113 patients were recruited between 2011 and 2013; investigators were able to evaluate 42 patients at four months and 29 patients at six months. The median survival for the participants was 6.8 months. Three patients (4.5 percent) experienced progression of their disease in the hippocampal region, which was within the expected range.

Dr. Mehta says that the radiation affects cognitive function by damaging nerve cells as well as stem cells, which help to regenerate nerve cells that support memory formation. "These stem-cell niches are exquisitely sensitive to radiation and are involved in neurogenesis – the process of generating new neurons, or nerve cells. Although we call it hippocampal-avoidance radiotherapy, we really are targeting the stem-cell niches in and around the hippocampus," Dr. Mehta says.

He notes that factors other than radiation may also contribute to cognitive decline in patients with brain metastases, including medicines to control seizures or swelling in the brain. The cancer itself may also have an effect.

### The research was supported by RTOG grant U10 CA21661 and CCOP grant U10 CA37422 from the National Cancer Institute (NCI).

About the University of Maryland School of Medicine Established in 1807, the University of Maryland School of Medicine is the first public medical school in the United States, and the first to institute a residency-training program. The School of Medicine was the founding school of the University of Maryland and today is an integral part of the 11-campus University System of Maryland. On the University of Maryland's Baltimore campus, the School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond. http://www.medschool.umaryland.edu.

About the University of Marlene and Stewart Greenebaum Cancer Center The University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated center in Baltimore affiliated with the University of Maryland Medical Center and University of Maryland School of Medicine, offers a multidisciplinary approach to treating all types of cancer and has an active cancer research program. It is ranked in the top 50 cancer programs in the nation by U.S. News & World Report. For more information, go to http://www.umgcc.org. END

ELSE PRESS RELEASES FROM THIS DATE:

Johns Hopkins researchers erase human brain tumor cells in mice

2013-09-24

Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of — and ultimately left no detectable trace of — brain tumor cells taken from adult human patients. The scientists targeted a mutation in the IDH1 gene first identified in human brain tumors called gliomas by a team of Johns Hopkins cancer researchers in 2008. This mutation was found in 70 to 80 percent of lower-grade and progressive forms of the brain cancer. The change occurs within a single spot along a string of thousands of genetic ...

Modifying rice crops to resist herbicide prompts weedy neighbors' growth spurt

2013-09-24

COLUMBUS, Ohio – Rice containing an overactive gene that makes it resistant to a common herbicide can pass that genetic trait to weedy rice, prompting powerful growth even without a weed-killer to trigger the modification benefit, new research shows. Previously, scientists have found that when a genetically modified trait passes from a crop plant to a closely related weed, the weed gains the crop's engineered benefit – resistance to pests, for example – only in the presence of the offending insects. This new study is a surprising example of gene flow from crops to ...

Baylor professors use whale earwax to develop new method to determine contaminant exposure in whales

2013-09-24

WACO, Texas (Sept. 23, 2013) — Baylor University professors Stephen Trumble, Ph.D., and Sascha Usenko, Ph.D., have developed a novel technique for reconstructing contaminant and hormone profiles using whale earplugs, determining—for the first time—lifetime chemical exposures and hormone profiles—from birth to death—for an individual whale, information that was previously unattainable. (Find this story on our website: http://www.baylor.edu/mediacommunications/news.php?action=story&story=132825) Using a blue whale's earplug, Trumble and Usenko were able to extract and ...

Fossil record shows crustaceans vulnerable as modern coral reefs decline

2013-09-24

GAINESVILLE, Fla. — Many ancient crustaceans went extinct following a massive collapse of reefs across the planet, and new University of Florida research suggests modern species living in rapidly declining reef habitats may now be at risk. Available online and scheduled to appear in the November issue of Geology, the study shows a direct correlation between the amount of prehistoric reefs and the number of decapod crustaceans, a group that includes shrimp, crab and lobster. The decline of modern reefs due to natural and human-influenced changes also could be detrimental, ...

Stanford scientists publish theory, formula to improve 'plastic' semiconductors

2013-09-24

Anyone who's stuffed a smart phone in their back pocket would appreciate the convenience of electronic devices that could bend. Flexible electronics could spawn new products: clothing wired to cool or heat, reading tablets that could fold like newspaper, and so on. Alas, electronic components such as chips, displays and wires are generally made from metals and inorganic semiconductors -- materials with physical properties that make them fairly stiff and brittle. In the quest for flexibility many researchers have been experimenting with semiconductors made from plastics ...

Data from across globe defines distinct Kawasaki disease season

2013-09-24

After more than four decades of research, strong evidence now shows that Kawasaki disease has a distinct seasonal occurrence shared by regions across the Northern hemisphere. The first global analysis of the seasonality of Kawasaki disease, published September 18 by PLOS ONE, was carried out using data obtained between 1970 and 2012. It included 296,203 cases from 39 locations in 25 countries around the globe, with 27 of those locations in the extra-tropical Northern hemisphere, eight in the tropics, and four in the extra-tropical Southern hemisphere. Kawasaki disease ...

UCSB researchers make headway in quantum information transfer via nanomechanical coupling

2013-09-24

(Santa Barbara, Calif.) –– Fiber optics has made communication faster than ever, but the next step involves a quantum leap –– literally. In order to improve the security of the transfer of information, scientists are working on how to translate electrical quantum states to optical quantum states in a way that would enable ultrafast, quantum-encrypted communications. A UC Santa Barbara research team has demonstrated the first and arguably most challenging step in the process. The paper, published in Nature Physics, describes a nanomechanical transducer that provides strong ...

Preoperative blood typing may not be needed for some pediatric surgeries

2013-09-24

Certain pediatric surgeries carry such low risk of serious blood loss that clinicians can safely forgo expensive blood typing and blood stocking before such procedures, suggest the results of a small study by researchers at the Johns Hopkins Children's Center. The finding, published ahead of print in the journal Pediatric Anesthesia, was accompanied by a list of 10 operations with "zero" transfusion risk, according to the investigators who reviewed the records of thousands of pediatric surgeries performed at The Johns Hopkins Hospital over 13 months. Unnecessary pre-emptive ...

UCLA engineers develop a stretchable, foldable transparent electronic display

2013-09-24

Imagine an electronic display nearly as clear as a window, or a curtain that illuminates a room, or a smartphone screen that doubles in size, stretching like rubber. Now imagine all of these being made from the same material. Researchers from UCLA's Henry Samueli School of Engineering and Applied Science have developed a transparent, elastic organic light-emitting device, or OLED, that could one day make all these possible. The OLED can be repeatedly stretched, folded and twisted at room temperature while still remaining lit and retaining its original shape. OLED ...

Researchers discover a new way that influenza can infect cells

2013-09-24

SEATTLE – Scientists at Fred Hutchinson Cancer Research Center have uncovered a new mechanism by which influenza can infect cells – a finding that ultimately may have implications for immunity against the flu. Influenza viruses have two main proteins on their surface that allow them to do their dirty work: a protein called hemagglutinin allows viruses to infect cells, while a protein called neuraminidase allows viruses to escape from cells. Now in a paper published online ahead of the December print issue of the Journal of Virology, Jesse Bloom, Ph.D., an evolutionary ...

Protecting specific area of the brain during radiation therapy substantially reduces memory loss

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: